|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2000-4-13
|
|
pubmed:abstractText |
Intranasal budesonide aqueous nasal spray (BANS) is recognized as an efficacious treatment for seasonal allergic rhinitis (SAR), but the time to onset of action is not known.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0091-6749
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
105
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
489-94
|
|
pubmed:dateRevised |
2005-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:10719298-Administration, Intranasal,
pubmed-meshheading:10719298-Adult,
pubmed-meshheading:10719298-Budesonide,
pubmed-meshheading:10719298-Double-Blind Method,
pubmed-meshheading:10719298-Humans,
pubmed-meshheading:10719298-Inspiratory Capacity,
pubmed-meshheading:10719298-Patient Satisfaction,
pubmed-meshheading:10719298-Rhinitis, Allergic, Seasonal,
pubmed-meshheading:10719298-Therapeutic Equivalency,
pubmed-meshheading:10719298-Time Factors
|
|
pubmed:year |
2000
|
|
pubmed:articleTitle |
Onset of action of intranasal budesonide (Rhinocort aqua) in seasonal allergic rhinitis studied in a controlled exposure model.
|
|
pubmed:affiliation |
Department of Medicine, Queen's University, Kingston; the Division of Allergy and Immunology, Kingston General Hospital, Kingston.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial
|
